Literature DB >> 3584851

Rebound elevation of cortisol following cyproheptadine withdrawal in Cushing's disease from a pituitary macroadenoma.

T C Ooi, Y Twum-Barima.   

Abstract

A 44-year-old female with Cushing's disease associated with a pituitary macroadenoma was treated with cyproheptadine, 24 mg per day, after partial surgical resection of the tumor. A large residual tumor remained. There was no clear suppression of serum and urinary cortisol during therapy, but both levels rose markedly to beyond pre cyproheptadine levels, on withdrawal of the drug. This is the first report on the use of cyproheptadine in Cushing's disease associated with a pituitary macroadenoma. The response in this patient indicates an influence of cyproheptadine on ACTH secretion by the macroadenoma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3584851     DOI: 10.1007/BF03347166

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  17 in total

1.  More on cyproheptadine.

Authors:  J B Tyrrell; R M Brooks; P H Forsham
Journal:  N Engl J Med       Date:  1976-11-11       Impact factor: 91.245

2.  Letter: Cyproheptadine for pituitary disorders.

Authors: 
Journal:  N Engl J Med       Date:  1976-08-12       Impact factor: 91.245

Review 3.  Physiopathology of Cushing's disease.

Authors:  D T Krieger
Journal:  Endocr Rev       Date:  1983       Impact factor: 19.871

4.  Cushing's disease: failure of treatment with cyproheptadine.

Authors:  J Allgrove; P Husband; C G Brook
Journal:  Br Med J       Date:  1977-03-12

5.  Cyproheptadine for Cushing's disease (cont.)

Authors:  R Scott; E A Espiner; R A Donald
Journal:  N Engl J Med       Date:  1977-01-06       Impact factor: 91.245

6.  Successful treatment with sodium valproate of a patient with Cushing's disease and gross enlargement of the pituitary.

Authors:  H P Koppeschaar; R J Croughs; J W van't Verlaat; M J Hendriks; C J Arts; J H Thijssen; F Schwarz
Journal:  Acta Endocrinol (Copenh)       Date:  1984-12

7.  Prolonged remission of a case of Cushing's disease following cessation of cyproheptadine therapy.

Authors:  M Wiesen; F Ross; D T Krieger
Journal:  Acta Endocrinol (Copenh)       Date:  1983-03

Review 8.  Cushing's syndrome: problems in management.

Authors:  D C Aron; J W Findling; P A Fitzgerald; P H Forsham; C B Wilson; J B Tyrrell
Journal:  Endocr Rev       Date:  1982       Impact factor: 19.871

9.  Effectiveness of cyproheptadine in decreasing plasma ACTH concentrations in Nelson's syndrome.

Authors:  D T Krieger; M Luria
Journal:  J Clin Endocrinol Metab       Date:  1976-11       Impact factor: 5.958

10.  Cyproheptadine in the control of Cushing's disease.

Authors:  T H Hsu; D S Gann; K W Tsan; R P Russell
Journal:  Johns Hopkins Med J       Date:  1981-08
View more
  1 in total

Review 1.  The Treatment of Cushing's Disease.

Authors:  Rosario Pivonello; Monica De Leo; Alessia Cozzolino; Annamaria Colao
Journal:  Endocr Rev       Date:  2015-06-11       Impact factor: 19.871

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.